Pertussis Clinical Trials

13 recruiting

Pertussis Trials at a Glance

19 actively recruiting trials for pertussis are listed on ClinicalTrialsFinder across 6 cities in 16 countries. The largest study group is Not Applicable with 4 trials, with the heaviest enrollment activity in Créteil, Bordeaux, and Chandigarh. Lead sponsors running pertussis studies include Association Clinique Thérapeutique Infantile du val de Marne, CanSino Biologics Inc., and Associate Professor John Sinn.

Browse pertussis trials by phase

Treatments under study

About Pertussis Clinical Trials

Looking for clinical trials for Pertussis? There are currently 13 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Pertussis trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Pertussis clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 119 of 19 trials

Recruiting
Not Applicable

Enhancing Maternal Vaccine Knowledge and Uptake: The InTroDuce-Programme Trial

KnowledgeVaccination UptakeInfluenza+1 more
Universiti Putra Malaysia351 enrolled4 locationsNCT06815250
Recruiting
Phase 4

Concurrent Versus Sequential Administration of Tdap and RSV Vaccines in Pregnancy

PregnancyHealthyRSV+1 more
Canadian Immunization Research Network60 enrolled4 locationsNCT07097012
Recruiting

Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective

Streptococcus PneumoniaeMalariaMeningitis+55 more
Institut Pasteur du Cambodge10,000 enrolled1 locationNCT07358910
Recruiting
Phase 1

Clinical Trial of the Adsorbed Acellular Pertussis (Tricomponent) DTaP-Haemophilus Influenzae Type b (Conjugate)-ACYW135 Group Meningococcal (Conjugate) Combined Vaccine

Diphtheria, Tetanus and Acellular PertussisEpidemic MeningitisHaemophilus Influenzae Type B Infection
CanSino Biologics Inc.260 enrolled1 locationNCT07203755
Recruiting
Phase 1Phase 2

A Phase I/II Study to Evaluate the Safety and Immunogenicity of GC3111B in Healthy Adults

Tetanus-diphtheria-acellular Pertussis (Tdap)
GC Biopharma Corp120 enrolled1 locationNCT06997627
Recruiting
Phase 2Phase 3

A Phase II/III Study to Evaluate the Immunogenicity, Safety and Lot-to-lot Consistency of LBVD, a Fully Liquid Hexavalent Diphtheria-tetanus-whole Cell Pertussis-hepatitis B-poliovirus-Haemophilus Influenzae Type b Conjugate (DTwP-HepB-IPV-Hib) Vaccine, in Healthy Infants as Primary Series

DiphtheriaPoliomyelitisHepatitis B+3 more
LG Chem1,186 enrolled1 locationNCT06947499
Recruiting
Phase 4

10-year Follow-up After a Single Dose Acellular Pertussis Vaccination

Pertussis
Mahidol University126 enrolled2 locationsNCT06803524
Recruiting
Not Applicable

Periscope Phase C Bordetella Pertussis Human Challenge Study With Delayed Antibiotic Therapy for 6 Weeks

Pertussis/Whooping Cough
University of Southampton72 enrolled1 locationNCT05847322
Recruiting
Phase 4

Assessing Interventions to Increase Tdap Acceptance for Non-birthing Partners in Pregnancy

Tdap - Tetanus, Diphtheria and Acellular Pertussis VaccinationNon-birthing Partner Vaccination in PregnancyVaccine Exposure During Pregnancy
Women and Infants Hospital of Rhode Island150 enrolled1 locationNCT06135636
Recruiting
Not Applicable

Safety and Immunogenicity of DTaP-IPV/Hib Pentavalent Vaccine in Chinese 2-month-old Infants

DiphtheriaPolioPertussis+2 more
Jiangsu Province Centers for Disease Control and Prevention785 enrolled1 locationNCT06605755
Recruiting
Phase 3

Clinical Study to Assess the Immunogenicity and Safety of Hexavalent Vaccine Containing Reduced Dose IPV

Diptheria ImmunizationTetanus ImmunizationPertussis Immunization+3 more
Serum Institute of India Pvt. Ltd.1,557 enrolled9 locationsNCT06413121
Recruiting

The Optimal Timing of Vaccination in Pregnancy

Pertussis/Whooping Cough
Elke Leuridan, MD, PhD96 enrolled1 locationNCT06466629
Recruiting
Not Applicable

Impact of Bacterial Expression and Immune Response in the Severity of Pertussis

Bordetella Pertussis, Whooping Cough
Institut Pasteur210 enrolled14 locationsNCT05897879
Recruiting

Prevalence and Impact of Pertussis and RSV on Asthma Severity and Control

AsthmaRSV InfectionPertussis
Hospital Clinico Universitario de Santiago784 enrolled1 locationNCT06286007
Recruiting

Pediatric Pertussis in Ambulatory Settings

Children, OnlyPertussis/Whooping CoughAmbulatory
Association Clinique Thérapeutique Infantile du val de Marne898 enrolled1 locationNCT04807712
Recruiting
Phase 1

Phase I Clinical Trial of Diphtheria-Tetanus-acellular Pertussis Component Combined Vaccine

DiphtheriaPertussisTetanus
Institute of Medical Biology, Chinese Academy of Medical Sciences460 enrolled3 locationsNCT06184542
Recruiting

Funded pharmacy vaccination of pregnant women: uptake and views and experiences

PregnancyVaccinationPertussis+1 more
Dr Natalie Gauld27,000 enrolled1 locationACTRN12616001453471
Recruiting

The Maternal Pertussis Randomised Control Trial: best practice for the communication of pertussis booster vaccine recommendations to new mothers.

Pertussis
Associate Professor John Sinn1,080 enrolled1 locationACTRN12613000580774
Recruiting
Phase 3Phase 4

Does early whooping cough (pertussis) vaccination provide earlier antibody protection for infants?

Pertussis infection
National Centre for Immunisation Research and Surveillance80 enrolled1 locationACTRN12605000013662